India Decodes TB Bacteria
- Hits: 1674
12 April 2010
New Delhi, India
It will pave way for a cost effective drug of the disease
Indian scientists have mapped the Mycobacterium tuberculosis genome, a first of its kind achievement that gives hope of discovering a cost effective drug for the disease that kills at least 330,000 Indians every year.
“Our scientists along with over 100 science students from several universities have done this within a few months. We hope within 18–24 months we will be able to take one molecule to the clinical trial stage,” Council for Scientific and Industrial Research (CSIR) Chief Samir Bramhachari said, reports IANS.
“I am too excited. What we have not done so far has been achieved. I thank all those students who have helped it become a reality. We are doing this through open source drug discovery (OSDD) and anyone across the world is free to join the effort,” Bramhachari added.
Scientists said that though 1.7 million people die of TB every year globally, there has not been any new drug discovery in last four to five decades.
OSDD is a completely new formula across the world. Here we are making all our progress available to public. Anyone can take advantage and develop a drug based on our research. The aim here is not patents but drug discovery for a neglected disease, Rajesh Gokhle, a senior scientist associated with the project said.